Clinical research indicates that L-carnitine supplementation in HF patients raises myocardial ATP levels, improves LVEF, reduces (NT-proBNP levels, and improves overall clinical outcomes (Agrawal et al., 2022). This evidence concerns the gene NPPB and hydrops fetalis.